-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Avadel Pharmaceuticals Plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2024.
- Avadel Pharmaceuticals Plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 95.1M shares, a 18.7% increase year-over-year.
- Avadel Pharmaceuticals Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 95.1M shares, a 18.7% increase from 2023.
- Avadel Pharmaceuticals Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 80.2M shares, a 33.4% increase from 2022.
- Avadel Pharmaceuticals Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 60.1M shares, a 2.66% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)